By Senad Karaahmetovic Moderna (NASDAQ:MRNA) CEO Stéphane Bancel announced his plan to donate to charity all of the after-tax proceeds of the original stock options he received upon...
By Liz Moyer Investing.com -- Pfizer Inc (NYSE:PFE) shares rose after the Food and Drug Administration approved its Covid-19 booster shot for children aged 5 to 11. Pfizer stock rose...
Shares of Moderna (NASDAQ:MRNA) are up 5% in premarket trading Wednesday after the company reported better-than-expected Q1 revenue.The pharmaceutical company reported a Q1 EPS of $8.58,...
Pre-Open Stock Movers:Livent Corporation (NYSE:LTHM) 26% HIGHER; reported Q1 EPS of $0.28, $0.15 better than the analyst estimate of $0.13. Revenue for the quarter came in at $143.5 million...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Wednesday, May 4th. Please refresh for updates. Lyft (NASDAQ:LYFT) stock slumped 23% after the ride-sharing...
Moderna (NASDAQ:MRNA) reported Q1 EPS of $8.58, $3.37 better than the analyst estimate of $5.21. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $4.62...
By Liz Moyer Investing.com -- U.S. stocks opened higher as tech companies led by Meta Platforms Inc posted positive results, allowing investors to shake off negative news on economic...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Technology, Consumer Services and Healthcare sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Healthcare, Telecoms and Consumer Services sectors propelled shares lower. At the close in NYSE, the Dow...
Goldman Sachs strategist John Marshall says that single-stock options market positioning suggests that investors are “unusually fearful” ahead of the earnings season. Investors are...
By Geoffrey Smith Investing.com -- Hoth Therapeutics (NASDAQ:HOTH) stock more than doubled in early trade on Monday after the biotech startup said that its experimental cancer treatment...
By Dhirendra Tripathi Investing.com -- Moderna (NASDAQ:MRNA) stock fell 4% Tuesday as reports came in that two large buyers have declined options to purchase more of its Covid-19...
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Oil & Gas, Utilities and Financials sectors propelled shares higher while losses in the Technology, Consumer...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Consumer Goods, Technology and Consumer Services sectors propelled shares higher. At the close in NYSE,...
By Geoffrey Smith Investing.com -- Stocks in focus in premarket trading on Friday, 18th March. Please refresh for updates. GameStop (NYSE:GME) stock fell 7.4% after it reported a surprise...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Technology, Consumer Services and Financials sectors propelled shares higher. At the close in NYSE, the...
By Dhirendra Tripathi Investing.com – Shares of vaccine makers traded higher Wednesday after Pfizer-BioNTech (NYSE:PFE) (NASDAQ:BNTX) sought U.S. FDA’s emergency use authorization for a...
By Sam Boughedda Investing.com -- Moderna Inc (NASDAQ:MRNA) has dosed the first participant in a clinical trial of an experimental human immunodeficiency virus (HIV) trimer mRNA vaccine,...
By Sam Boughedda Investing.com -- U.S. stocks traded in a volatile session on Monday, with the Dow rising early but then giving back some gains and the tech-heavy Nasdaq trading lower. Here...
By Geoffrey Smith Investing.com -- U.S. stock markets opened mixed on Monday as hopes for a diplomatic settlement to the war in Ukraine evaporated amid signs that Russia is pursuing its...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Tuesday, March 8th. Please refresh for updates. Shell (NYSE:SHEL) rose 0.8% after the oil major apologized for buying a...
By Dhirendra Tripathi Investing.com – Moderna (NASDAQ:MRNA) stock is trading sideways in premarket Tuesday after it signaled that it may begin to enforce patents of its Covid-19 vaccine...
(Bloomberg) -- Moderna (NASDAQ:MRNA) Inc.’s shares have dropped 50% this year as investors pulled back from Covid-19 healthcare stocks and staged a broader rotation out of growth...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Telecoms, Utilities and Oil & Gas sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Telecoms, Utilities and Oil & Gas sectors propelled shares higher. At the close in NYSE, the Dow Jones...
By Yasin Ebrahim Investing.com – The S&P 500 cut losses to close positive Thursday, led by dip-buying action in tech stocks after Russia launched a full-scale invasion of Ukraine. The S&P...
By Yasin Ebrahim Investing.com – The S&P 500 cut losses to turn positive Thursday, led by dip-buying action in tech stocks after Russia launched a full-scale invasion of Ukraine. The S&P 500...
By Dhirendra Tripathi Investing.com – Moderna , Inc. (NASDAQ:MRNA) stock surged 11.2% Thursday after the company forecast higher vaccine sales for the second half of the year, pinning its...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Thursday, February 24th. Please refresh for updates. eBay (NASDAQ:EBAY) stock fell 9.2% after the ecommerce...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
